Home
News
Interviews
Companies
Videos
Markets
Subscribe
Recent News
Filter by Category
News
Spotlight
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filter by Company
Clearmind Medicine
w
Woven Science
w
Ketamine One
w
IntelGenx
w
Wesana Health
w
Fluence
w
The Good Shroom Co
w
Mycrodose Therapeutics
w
Seelos Therapeutics
w
Horizons ETFs Management Inc.
w
Aja Ventures
w
Algernon Pharmaceuticals
w
Creso Pharma
w
Psilotec Health Solutions
w
Silo Wellness
w
Filament Health
w
Levitee Labs
w
Bionomics
w
Mindset Pharma
w
Psyence Group
w
CB Therapeutics
w
Small Pharma
w
Bexson Biomedical
w
Diamond Therapeutics
w
PsyBio Therapeutics
w
Nova Mentis Life Science
w
Psyched Wellness
w
Pharmather
w
Optimi Health
w
MINDCURE
w
Lophora
w
Unlimited Sciences
w
Doseology Sciences
w
Magical Brands
w
Tryp Therapeutics
w
MagicMed Industries
w
Core One Labs Inc.
w
Novamind Inc.
w
GoodCap Wellness
w
Pharmadrug Inc.
w
EGF Theramed Health Corp
w
Revive Therapeutics
w
Beckley Psytech
w
Awakn Life Sciences
w
TheraPsil
w
Lobe Sciences
w
Havn Life
w
Pure Extracts Corp
w
Red Light Holland
w
Orthogonal Thinker
w
MAPS
w
Mydecine Innovations Group
w
NeonMind Biosciences Inc.
w
Molecular Science Corp.
w
Wake Network
w
Gilgamesh Pharmaceuticals
w
Eleusis
w
Entheon Biomedical
w
Octarine Bio
w
Psygen Labs
w
EI.ventures
w
Compass Pathways
w
ATAI Life Sciences
w
Mind Medicine (MindMed)
w
Field Trip Health
w
Cybin Inc.
w
Braxia Scientific Corp.
w
Numinus
w
News
PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund
September 21, 2021
Pharmather
News
DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder
September 21, 2021
ATAI Life Sciences
News
Ketamine One Signs LOI with Veteran Services USA to Open Therapy Center
September 21, 2021
Ketamine One
News
Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug
September 21, 2021
Clearmind Medicine
News
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
September 20, 2021
Novamind Inc.
News
PsyBio Therapeutics Announces Participation in Upcoming Investor Conferences in September 2021
September 20, 2021
PsyBio Therapeutics
News
Small Pharma Included in AdvisorShares® Newly Launched Psychedelics ETF
September 20, 2021
Small Pharma
News
Algernon Pharmaceuticals Announces Plans for a Phase 2 Ifenprodil Chronic Cough Study in the U.S.
September 20, 2021
Algernon Pharmaceuticals
News
MINDCURE to Participate in Maxim Group LLC's Advances in Mental Health Virtual Conference
September 17, 2021
MINDCURE
News
PsyBio Therapeutics Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund
September 17, 2021
PsyBio Therapeutics
News
Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
September 17, 2021
MagicMed Industries
News
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
September 16, 2021
NeonMind Biosciences Inc.
News
Tryp Therapeutics to Present at Oppenheimer Fall Healthcare Summit
September 16, 2021
Tryp Therapeutics
News
MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental Health Industry
September 16, 2021
MINDCURE
News
Novamind to Present at Life Sciences Investor Forum
September 15, 2021
Novamind Inc.
News
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
September 15, 2021
Lobe Sciences
Previous
Next
